Market Indices
Sector Heatmap
LBRX — LB Pharmaceuticals Inc Common Stock
NasdaqLB Pharmaceuticals Inc Common Stock
- O
- 36.41
- H
- 36.88
- L
- 34.47
- V
- 492.36K
LBRX — Latest News & Headlines
9 StoriesLB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated "Moderate Buy" by Sell-Side Analysts - MarketBeat
LB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated "Moderate Buy" by Sell-Side Analysts MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% Following Analyst Downgrade - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% Following Analyst Downgrade MarketBeat
Needham initiates LB Pharmaceuticals stock with buy rating - Investing.com
Needham initiates LB Pharmaceuticals stock with buy rating Investing.com
Needham initiates coverage of LB Pharmaceuticals with Buy rating, $68 price target - TradingView
Needham initiates coverage of LB Pharmaceuticals with Buy rating, $68 price target TradingView
This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga
Roth/MKM Downgrades LB Pharmaceuticals Inc (LBRX) to Neutral - StreetInsider
Roth/MKM Downgrades LB Pharmaceuticals Inc (LBRX) to Neutral StreetInsider
LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Strong Sell" at Wall Street Zen - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Strong Sell" at Wall Street Zen MarketBeat
Needham & Company LLC Upgrades LB Pharmaceuticals (NASDAQ:LBRX) to "Moderate Buy" - MarketBeat
Needham & Company LLC Upgrades LB Pharmaceuticals (NASDAQ:LBRX) to "Moderate Buy" MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Neutral" at Roth Capital - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to "Neutral" at Roth Capital MarketBeat